FDA recall, , Moderate risk
Right Value Drug Stores Testosterone Cypionate
Testosterone Cypionate, 200 mg/mL, lacks sterility assurance.
Summary by Recall Canary from the FDA notice
What happened
Right Value Drug Stores LLC is recalling Testosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials and b) 30 m vials, due to lack of sterility assurance. The recall began on October 9, 2026, and was classified by the FDA on October 19, 2026. The product was distributed nationwide in the USA.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Testosterone Cypionate, 200 mg/mL
- NDC
- 73271-1225-1
- 73271-1226-2
- Lot code
- 10212025
Recall details
- Company began the recall
- Sold in
Nationwide in the USA.
- Company
- Right Value Drug Stores LLC
- Hazard
- Sterility problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 100109
- Recall number
- D-0070-2027
- Quantity recalled
- 4675 vials
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Classified by FDA
Added to FDA's Enforcement Report
Listed on Recall Canary
